SlideShare a Scribd company logo
Abdul-Kader Souid
↓ Neutrophil Count (Neutropenia)
• Inherited (bone marrow examination is necessary):
• Neutropenia, severe congenital, 1, AD; SCN1 (MIM#202700); mutations in
ELANE (MIM#130130)
• Cyclic neutropenia, AD (MIM#162800); mutations in ELANE
(MIM#130130)
• Neutropenia, severe congenital, 3, AR; SCN3 (MIM#610738); mutations in
HAX1 (MIM#605998)
• Acquired: Viral infection (common), drug-induced (common), bone marrow
failure syndrome (rare)
↓ Neutrophil Function
• Granulomatous disease, chronic, X-linked (XLR); CDGX (MIM#306400): A
primary immunodeficiency (defective microbial killing); mutations in CYBB
(MIM#300481).
• Hyper-IgE recurrent infection syndrome (HIES), AD (MIM#147060): A
primary immunodeficiency characterized by chronic eczema, recurrent
Staphylococcal infections, ↑serum IgE, and eosinophilia due to STAT3
(MIM#102582) mutations.
Disorders of MyelopoiesisMust know
AD, autosomal dominant; AR, autosomal recessive; XLR, X-linked recessive
Myelopoiesis
• Hematopoiesis: Hematopoietic multipotent (stem) cells can differentiate to →
erythrocytes, megakaryocytes, neutrophils, eosinophils, basophils, monocytes,
T lymphocytes, B lymphocytes, natural killer cells, dendritic cells, and mast cells.
• Myelopoiesis I: Multipotent (stem) cell → CFU-GEMM (CD34+/ HLA-DR+).
• Myelopoiesis II: CFU-GEMM → CFU-GM (CD34+/ HLA-DR+/ CD-64+).
– CFU-GM is driven by the growth factors c-kit ligand, IL-3, IL-6, and GM-CSF.
• Myelopoiesis III: CFU-GM → CFU-G (CD34+/ HLA-DR+/ CD-64+).
– CFU-G is driven by the growth factor G-CSF.
CFU: Colony forming units that grow at 37ºC in semisolid medium as pure colonies in 7 days.
CFU-GEMM: Colony forming units of precursor to granulocytes, erythrocytes, macrophages
(monocytes), and megakaryocytes.
CFU-GM: Colony forming units of precursor to granulocytes and monocytes/macrophages.
CFU-G: Colony forming units of precursor to granulocytes.
GM-CSF: Granulocyte-macrophage colony-stimulating factor.
G-CSF: Granulocyte colony-stimulating factor.
CFU-GEMM CFU-GM CFU-G
Reading
Neutrophil Function
(1) Neutrophil entrance from marrow to circulation.
(2) Rolling & tethering (adherence, mediated by selectins).
(3) Adhesion: Activated endothelial cells express
intercellular adhesion molecules (ICAM), which serve
as ligands for neutrophil β2 integrins (impaired in
‘leukocyte adhesion deficiency’, LAD).
(4) Invasion through the vascular basement
membrane with release of proteases and reactive
oxidative intermediates, destructing extracellular
matrix and allowing migration into tissue (impaired
in chronic granulomatous disease).
(5-6) Uptake of pathogens into the phagocytic vacuole with concomitant degranulation both into the
phagocytic vacuole and to the exterior (impaired in Chédiak-Higashi).
(7) Chemokines [IL-8, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory
protein (MIP)-1α, and IL-1β] recruit cells of the immune system (impaired in hyper-IgE syndrome).
(8) Extracellular traps are extrusions of chromatin and cationic bactericidal granule proteins.
Reading
Neutrophil Function
Chemotaxis → Motility → Adhesion→ Ingestion → Killing
9/26/2018
Lysis of the cytoplasmic granule (G)
against two ingested zymosan
particles (Z). The dense body of the
granule disappears from view in the
interval of 5 sec. (J Exp Med
1962;116:827)
Taxis = motion or orientation
Zymosan = a glucan of repeating glucose units found on surface of fungi.
This degranulation
process is impaired in
Chédiak-Higashi
disease
Must know
Neutrophil “Respiratory Burst”
Most homes have a bottle of hypochlorite (Ocl-) in the kitchen or bathroom
(Domestos, Chlorox, etc.); as advertised, these products kills all household germs.
These reactions are
impaired in chronic
granulomatous disease
(↓killing of catalase-
positive bacteria)
Chronic granulomatous disease → infections with catalase-positive organisms
(Staphylococcus aureus, Serratia marcescens, Acinetobacter anitratus, Salmonella,
Burkholderia cepacia, Aspergillus, Nocardia) → necrotizing granulomas. Initial diagnosis
is made by the oxidative burst flow cytometry test (phagocytes fail to oxidize rhodamine).
Must know
Bacterial Catalase
((catalase-positive bacteria)
H2O + ½O2
6
Hyper-IgE recurrent infection syndrome (HIES), AD (MIM#147060): A primary
immunodeficiency characterized by chronic eczema, recurrent Staphylococcal
infections, ↑ serum IgE, and eosinophilia due to STAT3 (MIM#102582) mutations.
(impaired chemotaxis and cytokine production)
This patient (Malaysian) had severe, persistent atopic dermatitis (intense itching), severe
atopy (asthma and allergic rhinitis), and a recent invasive infection (right hip joint and
bone). One year ago, Staphylococcus aureus and varicella-zoster virus (VZV) infections.
He had a significant history of food allergy, such as crab and shrimps which severely
flare his skin disease.
The father has similar moderate-to-severe atopic dermatitis and allergic rhinitis. His
sister has a much milder atopic dermatitis. His maternal grandfather has asthma and
maternal aunt has atopic dermatitis.
Must know
Mutations in LYST (MIM#606897), which encodes a lysosomal
trafficking regulator protein
↓Neutrophil chemotaxis + ↓Degranulation → ↓Bactericidal activity
↓Platelet storage pool → Bleeding
↓Melanosomes → Albinism
7
Union of lysosomal (giant)
granules in Chédiak-Higashi
Albinism
Optional Degranulation Abnormality
Chédiak-Higashi Syndrome (CHS, OMIM#214500, AR)
8
Leukocyte adhesion deficiency, type I; LAD, AR (MIM#116920)
Mutations in ITGB2 (MIM#600065; integrin, beta-2)
(recurrent bacterial infections; impaired pus formation and wound healing)
Lack of CD18/CD11 surface adhesive glycoproteins (β2 integrins) on
neutrophil membranes → neutrophilia + pyogenic infections without
pus.
Infections in a toddler with leukocyte adhesion deficiency
Optional
Severe Congenital Neutropenia
• Recurrent otitis, gingivitis, pneumonia, enteritis, and bacteremia in early infancy.
• Neutrophil count is <0.2 ×109/L with monocytosis, anemia, and thrombocytosis.
• Bone marrow shows neutrophil maturation arrest at the myeloblast (no mature
neutrophils).
• Patients are at risk for developing acute myelogenous leukemia (AML).
• G-CSF is effective (↑increasing neutrophil counts & ↓infections).
• Hematopoietic transplantation is the only curative therapy.
9/26/2018 9
Must know
• Neutropenia, severe congenital, 1, AD; SCN1 (MIM#202700); mutations in
ELANE (MIM#130130)
• Neutropenia, severe congenital, 3, AR; SCN3 (MIM#610738); mutations in
HAX1 (MIM#605998)
• Recurrent neutropenia, with a cycle period of about 21 days.
• The diagnosis is established by measuring the neutrophil count twice a
week for eight consecutive weeks.
• Supportive care includes regular dental care, prompt antibacterial
therapy as needed, and genetic counseling.
• Granulocyte colony-stimulating factor (G-CSF) is given at the nadir of
the neutrophil counts.
Note: Mutations in the elastase gene are associated with both cyclic
neutropenia and severe congenital neutropenia.
Cyclic neutropenia, AD (MIM#162800); mutations in ELANE (MIM#130130)
Must know
• Neutropenia due to proliferative defect and ↑apoptosis of
early myeloid progenitor cells.
• Clinical findings begins in the neonatal period and include short
stature, inadequate weight gain, skeletal abnormalities, infections
(otitis media, sinusitis, pneumonia), and large stools (steatorrhea,
malabsorption, pancreatic exocrine deficiency), and marrow
failure.
– Imaging confirms extensive fatty replacement of the pancreas.
– The presentation resembles cystic fibrosis (sweat chloride is
normal in Shwachman syndrome and high in cystic fibrosis).
• The risk of evolution to myelodysplastic syndrome and acute
myelogenous leukemia is at least 20%.
• G-CSF raises the neutrophil counts.
• Hematopoietic stem cell transplantation is curative.
11
Shwachman-Diamond Syndrome 1; SDS1, AR
(MIM#260400); mutations in SBDS (MIM#607444)
Optional
1. Neutrophil respiratory burst defect + XLR +
catalase-positive pathogens
2. Giant neutrophil granules + albinism
3. Negative CD11/CD18 expression + neutrophilia
4. Eczema + infections + Stat 3 mutation
5. Pancreatic insufficiency + neutropenia + SBDS
mutation
6. Elastase gene (ELANE)
7. Risks of developing AML
8. Treatment with G-CSF
9. Hematopoietic stem cell transplantation
A. Severe congenital neutropenia
B. Shwachman-Diamond Syndrome
C. Cyclic neutropenia
D. Chronic granulomatous disease
E. Chédiak-Higashi syndrome
F. Leukocyte adhesion deficiency
G. Hyper IgE syndrome
Fever with neutropenia is best treated with monotherapy (meropenem, cefepime or
ceftazidime). Although these regimens do not cover methicillin-resistant Staphylococcus
aureus and coagulase-negative staphylococci, vancomycin should be withheld in low-risk
patients pending cultures in an effort to prevent vancomycin-resistant enterococci.
Must Know Pearls
Freifeld AG, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic
patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93. doi: 10.1093/cid/cir073.
Two brothers present to the clinic for evaluation of recurrent neutropenia. They suffer
from regular episodes of mucositis, sinusitis, otitis media, pharyngitis and tonsillitis.
Their maternal grandfather, mother, maternal aunt and her son all have neutropenia.
9/26/2018 13
0
500
1000
1500
2000
0 10 20 30 40 50
ANC
days
CBC on the 5-year-old boy reveals absolute neutrophil
count (ANC) of 300/mL (0.3 x109/L). The results of his
ANC over 45 days are shown. Blood smear shows normal
neutrophil morphology.
Which of the following is the most likely diagnosis?
A. Chédiak-Higashi syndrome
B. Leukocyte adhesion deficiency
C. Hyper IgE syndrome
D. Severe congenital neutropenia
E. Cyclic neutropenia

More Related Content

What's hot

Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
Ali Faris
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
utsav parmar
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaDebra G. Carnahan
 
Haemoglobin Genotype
Haemoglobin GenotypeHaemoglobin Genotype
Haemoglobin Genotype
Agatsa David
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
priya jaswani
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte count
SUNIL KUMAR PEDDANA
 
Cytochemical staining checked
Cytochemical staining checkedCytochemical staining checked
Cytochemical staining checked
BALRAM KRISHAN
 
Hb elect
Hb electHb elect
Leishman giemsa cocktail
Leishman giemsa cocktailLeishman giemsa cocktail
Leishman giemsa cocktail
ishita1994
 
Hematological changes in systemic diseases
Hematological changes in systemic diseasesHematological changes in systemic diseases
Hematological changes in systemic diseases
Janani Mathialagan
 
Structure and function of haemoglobin
Structure and function of haemoglobinStructure and function of haemoglobin
Structure and function of haemoglobin
Kiruththikan Yogaraja
 
Leukocytes - Advance Hematology
Leukocytes - Advance Hematology Leukocytes - Advance Hematology
Leukocytes - Advance Hematology
Ahmad Qudah
 
Demonstration of le cells
Demonstration of le cellsDemonstration of le cells
Demonstration of le cells
SHRUTHI VASAN
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
Pradeep Singh Narwat
 
Automation in hematology part 1
Automation in hematology part 1Automation in hematology part 1
Automation in hematology part 1
Dr. Varughese George
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin study
Dr. Rajesh Bendre
 
Megaloblastic anemia mak
Megaloblastic anemia makMegaloblastic anemia mak
Megaloblastic anemia mak
Bahoran Singh Rajput
 
Erythrocyte indices
Erythrocyte  indicesErythrocyte  indices
Erythrocyte indices
Dr. Pritika Nehra
 

What's hot (20)

Le cell
Le cellLe cell
Le cell
 
Hemoglobinopathies
HemoglobinopathiesHemoglobinopathies
Hemoglobinopathies
 
Hemolytic anemia
Hemolytic anemiaHemolytic anemia
Hemolytic anemia
 
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria
 
Haemoglobin Genotype
Haemoglobin GenotypeHaemoglobin Genotype
Haemoglobin Genotype
 
leukemoid reaction and leukemia
leukemoid reaction and leukemialeukemoid reaction and leukemia
leukemoid reaction and leukemia
 
Reticulocyte count
Reticulocyte countReticulocyte count
Reticulocyte count
 
Cytochemical staining checked
Cytochemical staining checkedCytochemical staining checked
Cytochemical staining checked
 
Hb elect
Hb electHb elect
Hb elect
 
Leishman giemsa cocktail
Leishman giemsa cocktailLeishman giemsa cocktail
Leishman giemsa cocktail
 
Hematological changes in systemic diseases
Hematological changes in systemic diseasesHematological changes in systemic diseases
Hematological changes in systemic diseases
 
Structure and function of haemoglobin
Structure and function of haemoglobinStructure and function of haemoglobin
Structure and function of haemoglobin
 
Leukocytes - Advance Hematology
Leukocytes - Advance Hematology Leukocytes - Advance Hematology
Leukocytes - Advance Hematology
 
Demonstration of le cells
Demonstration of le cellsDemonstration of le cells
Demonstration of le cells
 
Haemolytic anemia
Haemolytic anemia Haemolytic anemia
Haemolytic anemia
 
Metabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC EnzymopathiesMetabolism of RBC and RBC Enzymopathies
Metabolism of RBC and RBC Enzymopathies
 
Automation in hematology part 1
Automation in hematology part 1Automation in hematology part 1
Automation in hematology part 1
 
Interpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin studyInterpreting Abnormal hemoglobin study
Interpreting Abnormal hemoglobin study
 
Megaloblastic anemia mak
Megaloblastic anemia makMegaloblastic anemia mak
Megaloblastic anemia mak
 
Erythrocyte indices
Erythrocyte  indicesErythrocyte  indices
Erythrocyte indices
 

Similar to Disorders of myelopoiesis.ppt

Combined Immunodeficiency
Combined ImmunodeficiencyCombined Immunodeficiency
Combined Immunodeficiency
Su Cho
 
ALTERED ANTIGENS AND IMMUNODEFICIENCIES.
ALTERED ANTIGENS  AND IMMUNODEFICIENCIES.ALTERED ANTIGENS  AND IMMUNODEFICIENCIES.
ALTERED ANTIGENS AND IMMUNODEFICIENCIES.
KARTHIK REDDY C A
 
Disorders of lymphobioesis.ppt
Disorders of lymphobioesis.pptDisorders of lymphobioesis.ppt
Disorders of lymphobioesis.ppt
AbdulKaderSouid
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
Shobhita Katiyar
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
Shobhita Katiyar
 
Clinical immunology vinmukil
Clinical immunology vinmukilClinical immunology vinmukil
Clinical immunology vinmukil
Bharathidasan University trichy
 
LEUKEMIA.pptx
LEUKEMIA.pptxLEUKEMIA.pptx
LEUKEMIA.pptx
shiwani88
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptx
Chinmoy Sahu
 
Diagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderDiagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorder
PrernaChoudhary15
 
Wiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final PowerpointWiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final Powerpoint
Jefferson School of Education
 
Haemophagocytic Syndrome
Haemophagocytic SyndromeHaemophagocytic Syndrome
Haemophagocytic Syndrome軒名 林
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
dr.Ihsan alsaimary
 
seminar on MAS
seminar on MASseminar on MAS
seminar on MAS
Dr. Habibur Rahim
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
dr.Ihsan alsaimary
 
Complications of immunosuppression
Complications of immunosuppressionComplications of immunosuppression
Complications of immunosuppression
Sharath !!!!!!!!
 
Immuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondaryImmuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondary
Dr Lekshmi Priya
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
Raeez Basheer
 
MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
Manoj Aryal
 

Similar to Disorders of myelopoiesis.ppt (20)

Combined Immunodeficiency
Combined ImmunodeficiencyCombined Immunodeficiency
Combined Immunodeficiency
 
ALTERED ANTIGENS AND IMMUNODEFICIENCIES.
ALTERED ANTIGENS  AND IMMUNODEFICIENCIES.ALTERED ANTIGENS  AND IMMUNODEFICIENCIES.
ALTERED ANTIGENS AND IMMUNODEFICIENCIES.
 
Rheuma copy
Rheuma copyRheuma copy
Rheuma copy
 
Rheuma copy
Rheuma copyRheuma copy
Rheuma copy
 
Disorders of lymphobioesis.ppt
Disorders of lymphobioesis.pptDisorders of lymphobioesis.ppt
Disorders of lymphobioesis.ppt
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
 
Humoral Immunodeficiencies
Humoral ImmunodeficienciesHumoral Immunodeficiencies
Humoral Immunodeficiencies
 
Clinical immunology vinmukil
Clinical immunology vinmukilClinical immunology vinmukil
Clinical immunology vinmukil
 
LEUKEMIA.pptx
LEUKEMIA.pptxLEUKEMIA.pptx
LEUKEMIA.pptx
 
immunodef dis.pptx
immunodef dis.pptximmunodef dis.pptx
immunodef dis.pptx
 
Diagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorderDiagnostic approach to primary immunodefidiency disorder
Diagnostic approach to primary immunodefidiency disorder
 
Wiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final PowerpointWiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final Powerpoint
 
Haemophagocytic Syndrome
Haemophagocytic SyndromeHaemophagocytic Syndrome
Haemophagocytic Syndrome
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
 
seminar on MAS
seminar on MASseminar on MAS
seminar on MAS
 
Infections in immunocompromised patients
Infections in immunocompromised patientsInfections in immunocompromised patients
Infections in immunocompromised patients
 
Complications of immunosuppression
Complications of immunosuppressionComplications of immunosuppression
Complications of immunosuppression
 
Immuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondaryImmuno deficiency diseases- primary and secondary
Immuno deficiency diseases- primary and secondary
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
 
MULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryalMULTIPLE MYELOMA presented by dr manoj aryal
MULTIPLE MYELOMA presented by dr manoj aryal
 

More from AbdulKaderSouid

Thrombophilia.ppt
Thrombophilia.pptThrombophilia.ppt
Thrombophilia.ppt
AbdulKaderSouid
 
von willebrand disease.ppt
von willebrand disease.pptvon willebrand disease.ppt
von willebrand disease.ppt
AbdulKaderSouid
 
Blood banking and transfusion medicine i&amp;ii
Blood banking and transfusion medicine i&amp;iiBlood banking and transfusion medicine i&amp;ii
Blood banking and transfusion medicine i&amp;ii
AbdulKaderSouid
 
HUS.ppt
HUS.pptHUS.ppt
TTP.ppt
TTP.pptTTP.ppt
Hemophilia.ppt
Hemophilia.pptHemophilia.ppt
Hemophilia.ppt
AbdulKaderSouid
 
Hemostasis work up
Hemostasis work upHemostasis work up
Hemostasis work up
AbdulKaderSouid
 
Bone marrow failure syndromes.ppt
Bone marrow failure syndromes.pptBone marrow failure syndromes.ppt
Bone marrow failure syndromes.ppt
AbdulKaderSouid
 
Sickle cell disease.ppt
Sickle cell disease.pptSickle cell disease.ppt
Sickle cell disease.ppt
AbdulKaderSouid
 
G6PD deficiency.ppt
G6PD deficiency.pptG6PD deficiency.ppt
G6PD deficiency.ppt
AbdulKaderSouid
 
4 macrocytic anemia.ppt
4 macrocytic anemia.ppt4 macrocytic anemia.ppt
4 macrocytic anemia.ppt
AbdulKaderSouid
 
3 microcytic anemia ii-thalassemia trait.ppt
3 microcytic anemia ii-thalassemia trait.ppt3 microcytic anemia ii-thalassemia trait.ppt
3 microcytic anemia ii-thalassemia trait.ppt
AbdulKaderSouid
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt
AbdulKaderSouid
 
1 complete blood counts.ppt
1 complete blood counts.ppt1 complete blood counts.ppt
1 complete blood counts.ppt
AbdulKaderSouid
 

More from AbdulKaderSouid (14)

Thrombophilia.ppt
Thrombophilia.pptThrombophilia.ppt
Thrombophilia.ppt
 
von willebrand disease.ppt
von willebrand disease.pptvon willebrand disease.ppt
von willebrand disease.ppt
 
Blood banking and transfusion medicine i&amp;ii
Blood banking and transfusion medicine i&amp;iiBlood banking and transfusion medicine i&amp;ii
Blood banking and transfusion medicine i&amp;ii
 
HUS.ppt
HUS.pptHUS.ppt
HUS.ppt
 
TTP.ppt
TTP.pptTTP.ppt
TTP.ppt
 
Hemophilia.ppt
Hemophilia.pptHemophilia.ppt
Hemophilia.ppt
 
Hemostasis work up
Hemostasis work upHemostasis work up
Hemostasis work up
 
Bone marrow failure syndromes.ppt
Bone marrow failure syndromes.pptBone marrow failure syndromes.ppt
Bone marrow failure syndromes.ppt
 
Sickle cell disease.ppt
Sickle cell disease.pptSickle cell disease.ppt
Sickle cell disease.ppt
 
G6PD deficiency.ppt
G6PD deficiency.pptG6PD deficiency.ppt
G6PD deficiency.ppt
 
4 macrocytic anemia.ppt
4 macrocytic anemia.ppt4 macrocytic anemia.ppt
4 macrocytic anemia.ppt
 
3 microcytic anemia ii-thalassemia trait.ppt
3 microcytic anemia ii-thalassemia trait.ppt3 microcytic anemia ii-thalassemia trait.ppt
3 microcytic anemia ii-thalassemia trait.ppt
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt
 
1 complete blood counts.ppt
1 complete blood counts.ppt1 complete blood counts.ppt
1 complete blood counts.ppt
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 

Disorders of myelopoiesis.ppt

  • 1. Abdul-Kader Souid ↓ Neutrophil Count (Neutropenia) • Inherited (bone marrow examination is necessary): • Neutropenia, severe congenital, 1, AD; SCN1 (MIM#202700); mutations in ELANE (MIM#130130) • Cyclic neutropenia, AD (MIM#162800); mutations in ELANE (MIM#130130) • Neutropenia, severe congenital, 3, AR; SCN3 (MIM#610738); mutations in HAX1 (MIM#605998) • Acquired: Viral infection (common), drug-induced (common), bone marrow failure syndrome (rare) ↓ Neutrophil Function • Granulomatous disease, chronic, X-linked (XLR); CDGX (MIM#306400): A primary immunodeficiency (defective microbial killing); mutations in CYBB (MIM#300481). • Hyper-IgE recurrent infection syndrome (HIES), AD (MIM#147060): A primary immunodeficiency characterized by chronic eczema, recurrent Staphylococcal infections, ↑serum IgE, and eosinophilia due to STAT3 (MIM#102582) mutations. Disorders of MyelopoiesisMust know AD, autosomal dominant; AR, autosomal recessive; XLR, X-linked recessive
  • 2. Myelopoiesis • Hematopoiesis: Hematopoietic multipotent (stem) cells can differentiate to → erythrocytes, megakaryocytes, neutrophils, eosinophils, basophils, monocytes, T lymphocytes, B lymphocytes, natural killer cells, dendritic cells, and mast cells. • Myelopoiesis I: Multipotent (stem) cell → CFU-GEMM (CD34+/ HLA-DR+). • Myelopoiesis II: CFU-GEMM → CFU-GM (CD34+/ HLA-DR+/ CD-64+). – CFU-GM is driven by the growth factors c-kit ligand, IL-3, IL-6, and GM-CSF. • Myelopoiesis III: CFU-GM → CFU-G (CD34+/ HLA-DR+/ CD-64+). – CFU-G is driven by the growth factor G-CSF. CFU: Colony forming units that grow at 37ºC in semisolid medium as pure colonies in 7 days. CFU-GEMM: Colony forming units of precursor to granulocytes, erythrocytes, macrophages (monocytes), and megakaryocytes. CFU-GM: Colony forming units of precursor to granulocytes and monocytes/macrophages. CFU-G: Colony forming units of precursor to granulocytes. GM-CSF: Granulocyte-macrophage colony-stimulating factor. G-CSF: Granulocyte colony-stimulating factor. CFU-GEMM CFU-GM CFU-G Reading
  • 3. Neutrophil Function (1) Neutrophil entrance from marrow to circulation. (2) Rolling & tethering (adherence, mediated by selectins). (3) Adhesion: Activated endothelial cells express intercellular adhesion molecules (ICAM), which serve as ligands for neutrophil β2 integrins (impaired in ‘leukocyte adhesion deficiency’, LAD). (4) Invasion through the vascular basement membrane with release of proteases and reactive oxidative intermediates, destructing extracellular matrix and allowing migration into tissue (impaired in chronic granulomatous disease). (5-6) Uptake of pathogens into the phagocytic vacuole with concomitant degranulation both into the phagocytic vacuole and to the exterior (impaired in Chédiak-Higashi). (7) Chemokines [IL-8, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, and IL-1β] recruit cells of the immune system (impaired in hyper-IgE syndrome). (8) Extracellular traps are extrusions of chromatin and cationic bactericidal granule proteins. Reading
  • 4. Neutrophil Function Chemotaxis → Motility → Adhesion→ Ingestion → Killing 9/26/2018 Lysis of the cytoplasmic granule (G) against two ingested zymosan particles (Z). The dense body of the granule disappears from view in the interval of 5 sec. (J Exp Med 1962;116:827) Taxis = motion or orientation Zymosan = a glucan of repeating glucose units found on surface of fungi. This degranulation process is impaired in Chédiak-Higashi disease Must know
  • 5. Neutrophil “Respiratory Burst” Most homes have a bottle of hypochlorite (Ocl-) in the kitchen or bathroom (Domestos, Chlorox, etc.); as advertised, these products kills all household germs. These reactions are impaired in chronic granulomatous disease (↓killing of catalase- positive bacteria) Chronic granulomatous disease → infections with catalase-positive organisms (Staphylococcus aureus, Serratia marcescens, Acinetobacter anitratus, Salmonella, Burkholderia cepacia, Aspergillus, Nocardia) → necrotizing granulomas. Initial diagnosis is made by the oxidative burst flow cytometry test (phagocytes fail to oxidize rhodamine). Must know Bacterial Catalase ((catalase-positive bacteria) H2O + ½O2
  • 6. 6 Hyper-IgE recurrent infection syndrome (HIES), AD (MIM#147060): A primary immunodeficiency characterized by chronic eczema, recurrent Staphylococcal infections, ↑ serum IgE, and eosinophilia due to STAT3 (MIM#102582) mutations. (impaired chemotaxis and cytokine production) This patient (Malaysian) had severe, persistent atopic dermatitis (intense itching), severe atopy (asthma and allergic rhinitis), and a recent invasive infection (right hip joint and bone). One year ago, Staphylococcus aureus and varicella-zoster virus (VZV) infections. He had a significant history of food allergy, such as crab and shrimps which severely flare his skin disease. The father has similar moderate-to-severe atopic dermatitis and allergic rhinitis. His sister has a much milder atopic dermatitis. His maternal grandfather has asthma and maternal aunt has atopic dermatitis. Must know
  • 7. Mutations in LYST (MIM#606897), which encodes a lysosomal trafficking regulator protein ↓Neutrophil chemotaxis + ↓Degranulation → ↓Bactericidal activity ↓Platelet storage pool → Bleeding ↓Melanosomes → Albinism 7 Union of lysosomal (giant) granules in Chédiak-Higashi Albinism Optional Degranulation Abnormality Chédiak-Higashi Syndrome (CHS, OMIM#214500, AR)
  • 8. 8 Leukocyte adhesion deficiency, type I; LAD, AR (MIM#116920) Mutations in ITGB2 (MIM#600065; integrin, beta-2) (recurrent bacterial infections; impaired pus formation and wound healing) Lack of CD18/CD11 surface adhesive glycoproteins (β2 integrins) on neutrophil membranes → neutrophilia + pyogenic infections without pus. Infections in a toddler with leukocyte adhesion deficiency Optional
  • 9. Severe Congenital Neutropenia • Recurrent otitis, gingivitis, pneumonia, enteritis, and bacteremia in early infancy. • Neutrophil count is <0.2 ×109/L with monocytosis, anemia, and thrombocytosis. • Bone marrow shows neutrophil maturation arrest at the myeloblast (no mature neutrophils). • Patients are at risk for developing acute myelogenous leukemia (AML). • G-CSF is effective (↑increasing neutrophil counts & ↓infections). • Hematopoietic transplantation is the only curative therapy. 9/26/2018 9 Must know • Neutropenia, severe congenital, 1, AD; SCN1 (MIM#202700); mutations in ELANE (MIM#130130) • Neutropenia, severe congenital, 3, AR; SCN3 (MIM#610738); mutations in HAX1 (MIM#605998)
  • 10. • Recurrent neutropenia, with a cycle period of about 21 days. • The diagnosis is established by measuring the neutrophil count twice a week for eight consecutive weeks. • Supportive care includes regular dental care, prompt antibacterial therapy as needed, and genetic counseling. • Granulocyte colony-stimulating factor (G-CSF) is given at the nadir of the neutrophil counts. Note: Mutations in the elastase gene are associated with both cyclic neutropenia and severe congenital neutropenia. Cyclic neutropenia, AD (MIM#162800); mutations in ELANE (MIM#130130) Must know
  • 11. • Neutropenia due to proliferative defect and ↑apoptosis of early myeloid progenitor cells. • Clinical findings begins in the neonatal period and include short stature, inadequate weight gain, skeletal abnormalities, infections (otitis media, sinusitis, pneumonia), and large stools (steatorrhea, malabsorption, pancreatic exocrine deficiency), and marrow failure. – Imaging confirms extensive fatty replacement of the pancreas. – The presentation resembles cystic fibrosis (sweat chloride is normal in Shwachman syndrome and high in cystic fibrosis). • The risk of evolution to myelodysplastic syndrome and acute myelogenous leukemia is at least 20%. • G-CSF raises the neutrophil counts. • Hematopoietic stem cell transplantation is curative. 11 Shwachman-Diamond Syndrome 1; SDS1, AR (MIM#260400); mutations in SBDS (MIM#607444) Optional
  • 12. 1. Neutrophil respiratory burst defect + XLR + catalase-positive pathogens 2. Giant neutrophil granules + albinism 3. Negative CD11/CD18 expression + neutrophilia 4. Eczema + infections + Stat 3 mutation 5. Pancreatic insufficiency + neutropenia + SBDS mutation 6. Elastase gene (ELANE) 7. Risks of developing AML 8. Treatment with G-CSF 9. Hematopoietic stem cell transplantation A. Severe congenital neutropenia B. Shwachman-Diamond Syndrome C. Cyclic neutropenia D. Chronic granulomatous disease E. Chédiak-Higashi syndrome F. Leukocyte adhesion deficiency G. Hyper IgE syndrome Fever with neutropenia is best treated with monotherapy (meropenem, cefepime or ceftazidime). Although these regimens do not cover methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci, vancomycin should be withheld in low-risk patients pending cultures in an effort to prevent vancomycin-resistant enterococci. Must Know Pearls Freifeld AG, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56-93. doi: 10.1093/cid/cir073.
  • 13. Two brothers present to the clinic for evaluation of recurrent neutropenia. They suffer from regular episodes of mucositis, sinusitis, otitis media, pharyngitis and tonsillitis. Their maternal grandfather, mother, maternal aunt and her son all have neutropenia. 9/26/2018 13 0 500 1000 1500 2000 0 10 20 30 40 50 ANC days CBC on the 5-year-old boy reveals absolute neutrophil count (ANC) of 300/mL (0.3 x109/L). The results of his ANC over 45 days are shown. Blood smear shows normal neutrophil morphology. Which of the following is the most likely diagnosis? A. Chédiak-Higashi syndrome B. Leukocyte adhesion deficiency C. Hyper IgE syndrome D. Severe congenital neutropenia E. Cyclic neutropenia